Cell differences affect how HIV-1 responds to drugs
Researchers found that cell heterogeneity shapes how HIV-1 reacts to agents used to reverse latency.
Cell heterogeneity contributes to how HIV-1 responds to latency-reversing agents. This variability in response is linked to transcriptional noise.
Researchers used a dual-copy MS2-tagging system and mathematical analysis to study HIV-1 transcription in live cells. They investigated how transcription variability works in the basal state.
In the basal state, the transcriptional activity of proviruses in the same cell was uncorrelated. This indicates variability comes from the intrinsic stochasticity of promoter dynamics.
When using diverse latency-reversing agents, transcription of viral copies became more correlated within cells than across them. This shows a shift from promoter-driven to cell state-driven variability.
Analysis of molecular drug targets confirmed variable effects across cells. These findings offer mechanistic insights into HIV-1 latency.
The work informs strategies to target the latent viral reservoir. The origin and impact of transcriptional noise in HIV-1 latency remain incompletely characterized.
Key facts
- Transcriptional activity of proviruses in the same cell was uncorrelated in the basal state.
- Stimulation with latency-reversing agents causes a shift from promoter-driven to cell state-driven variability.
- Cellular heterogeneity shapes the response to latency-reversing agents.